-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ESroBa+T7q6IpHjAR0z7iFt0926Wcb9seN5Nnqve/RvJjdC/fur++SHWn3xj/7Xm Ee4uFBbil+Hr9dqhkYnMiQ== 0000950120-97-000046.txt : 19970222 0000950120-97-000046.hdr.sgml : 19970222 ACCESSION NUMBER: 0000950120-97-000046 CONFORMED SUBMISSION TYPE: SC 13G CONFIRMING COPY: PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970220 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DIGENE CORP CENTRAL INDEX KEY: 0001011582 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 521536128 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-46641 FILM NUMBER: 00000000 BUSINESS ADDRESS: STREET 1: 2301-B BROADBIRCH DR CITY: SILVER SPRING STATE: MD ZIP: 20904 BUSINESS PHONE: 3014706505 MAIL ADDRESS: STREET 1: 2301 B BROADBIRCH DRIVE CITY: SILVER SPRING STATE: MD ZIP: 20904 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MUREX DIAGNOSTICS CORP CENTRAL INDEX KEY: 0001034128 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: SECOND FLOOR TRIDENT HOUSE STREET 2: BREIDGETOWN ST MICHAEL CITY: BARBADOS STATE: C8 ZIP: 00000 SC 13G 1 SCHEDULE 13G OF MUREX DIAGNOSTICS CORPORATION THIS DOCUMENT IS A CONFIRMING COPY OF THE SCHEDULE 13G FILED ON FEBRUARY 14, 1997 PURSUANT TO A RULE 201 TEMPORARY HARDSHIP EXEMPTION. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION STATEMENT PURSUANT TO RULES 13d-1 and 13d-2 UNDER THE SECURITIES EXCHANGE ACT 1934(1) DIGENE CORPORATION ------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, $.01 PAR VALUE ------------------------------------------------------------------------- (Title of Class of Securities) 253752 10 9 ----------------- (CUSIP Number) Check the following box if a fee is being paid with this Statement. [ ] (A fee is not required only if the reporting person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class. (See Rule 13d-7.) -------------------- 1 The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 --------------------- ----------------- CUSIP No. 253752 10 9 13G Page 2 of 5 Pages --------------------- ----------------- -------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS MUREX DIAGNOSTICS CORPORATION -------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] -------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------- 4 SOURCE OF FUNDS* WC -------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) [ ] -------------------------------------------------------------------------- CITIZENSHIP OR PLACE OF ORGANIZATION -------------------------------------------------------------------------- NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: -------------------------------------------------------------------------- 7 SOLE VOTING POWER 736,546 -------------------------------------------------------------------------- 8 SHARED VOTING POWER - 0 - -------------------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER 736,546 -------------------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER - 0 - -------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 736,546 -------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] -------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.5% -------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* CO -------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT Page 2 SCHEDULE 13G ------------ ITEM 1(a). NAME OF ISSUER: -------------- Digene Corporation (the "Issuer"). ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: ----------------------------------------------- 9000 Virginia Manor Road Beltsville, Maryland 20705 ITEM 2(a). NAME OF PERSON FILING: --------------------- Murex Diagnostics Corporation ("Murex"). ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE: ------------------------------------ Murex Diagnostics Corporation Second Floor Trident House Bridgetown, St. Michael Barbados ITEM 2(c). CITIZENSHIP: ----------- Murex is a Barbados corporation. ITEM 2(d). TITLE OF CLASS OF SECURITIES: ---------------------------- Common Stock, $.01 par value ITEM 2(e). CUSIP NUMBER: ------------ 253752 10 9 ITEM 3. TYPE OF PERSON: -------------- Not applicable ITEM 4. OWNERSHIP. --------- (a) Amount Beneficially Owned: As of December 31, 1996, Murex owned 736,546 shares of the Issuer's Common Stock. (b) Percent of Class: 6.5% (c) Number of Shares as to which Murex has: (i) Sole power to vote or direct the vote: 736,546 shares; (ii) Shared power to vote or direct the vote: - 0 - shares; Page 3 (iii) Sole power to dispose or to direct the disposition of: 736,546 shares; (iv) Shared power to dispose or to direct the disposition of: - 0- shares. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. -------------------------------------------- Not applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ------------------------------------------------ ANOTHER PERSON. -------------- Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY --------------------------------------------------- WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE ---------------------------------------------------- PARENT HOLDING COMPANY. ---------------------- Not applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE --------------------------------------------------- GROUP. ----- Not applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP. ------------------------------ Not applicable. Page 4 ITEM 10. CERTIFICATION. ------------- By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE --------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and accurate. Dated: February 13, 1997 MUREX DIAGNOSTICS CORPORATION /s/ Lynwood S. Bell ---------------------------------- By: Lynwood S. Bell, Managing Director -----END PRIVACY-ENHANCED MESSAGE-----